Publications
The angiotensin-converting enzyme gene insertion/deletion polymorphism, an independent predictor of systolic cardiac performance in idiopathic dilated Cardiomyopathy
1998 - G. Candy, D. Skudicky, A.J. Woodiwiss, F. Luker, U. Muller, K. Sliwa, P. Sareli.
- Journal of the European Society of Cardiology. ( suppl): 38591
Long-term results of patients with post partum cardiomyopathy on “optimal medical therapy”
1998 - Sliwa K, Skudicky D, Bergemann A, Candy G, Sareli P.
- Cardiovascular Journal of Southern Africa
Effects of Pentoxifylline on Interleukin-6 plasma in patients with idiopathic dilated cardiomyopathy
1998 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
- Cardiovascular Journal of Southern Africa
Long-term effects of Pentoxifylline on Left ventricular function in patients with idiopathic dilated cardiomyopathy
1998 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
- Cardiovascular Journal of Southern Africa
The angiotensin-converting enzyme gene insertion/deletion ( I/D) polymorphism is independently associated with both a reduced left ventricular systolic performance and an increased cavity size in idiopathic dilated cardiomyopathy
1998 - Candy G, Skudicky D, Woodiwiss AJ, Luker F, Mueller U, Sliwa K, Sareli P, Norton GR.
- South African Journal of Science
Effects of Pentoxifylline on left ventricular function in patients with idiopathic dilated cardiomyopathy
1998 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
- One year results. Circulation (Suppl I);I-650
Pentoxifylline reduces Interleukin-6 plasma levels in patients with idiopathic dilated cardiomyopathy
1998 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
Long term effects of Pentoxifylline on left ventricular function in patients with idiopathic dilated cardiomyopathy
1999 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
- Journal of the European Society of Cardiology (suppl) P620
Pentoxifylline reduces Fas/APO-1 plasma levels in patients with idiopathic dilated cardiomyopathy
1999 - Skudicky D, Sliwa K, Candy G, Bergemann A, Sareli P.
- Circulation (suppl) :I-17
Baseline Plasma Levels of Tumor Necrosis Factor-alpha Predicts response to Treatment With Pentoxifylline in Patients with Idiopathic Dilated Cardiomyopathy
2000 - Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
- Journal of the American College of Cardiology (suppl) 352 A
